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Background: Nuss surgery is preferred in pectus excavatum repair because this procedure produces excellent 
cosmetic results and prevents postoperative distressed pulmonary function. However, the procedure causes severe 
pain due to thoracic expansion. This study was designed to investigate the analgesic effect of small doses of ketamine 
on an intravenous patient-controlled analgesia (IV-PCA) using hydromorphone and ketorolac for pain control after 
Nuss surgery.
Methods: Forty-four patients undergoing elective Nuss surgery were randomly assigned to receive hydromorphone 3 
μg/kg/hr, ketorolac 0.05 mg/kg/hr and ondansetron 0.1 mg/kg/day (Group HO, n = 22) or hydromorphone 3 μg/kg/
hr, ketorolac 0.05 mg/kg/hr, ondansetron 0.1 mg/kg/day and ketamine 0.15 mg/kg/hr (Group HK, n = 22) via an IV-
PCA pump after surgery. A blind observer evaluated each patient using the Modified Children’s Hospital of Eastern 
Ontario Pain Scale (CHEOPS) for the assessment of pain control. The total administered PCA volume, side effects and 
parents satisfaction with pain control were assessed at postoperative 1, 4, 8, 12, 24, and 48 hours.
Results: There were no significant differences in Modified CHEOPS between the groups during postoperative 48 
hours. The total PCA volume in group HK was significantly lower than that in group HO (P < 0.05). The side effects 
in both groups did not significantly differ except for pruritus. The levels of satisfaction from the parents were not 
significantly different between the groups. 
Conclusions: A small dose of ketamine on IV-PCA reduced the total administered dose of IV-PCA with 
hydromorphone and ketorolac and reduced the incidence of pruritus after the Nuss procedure in pediatric patients. 
(Korean J Anesthesiol 2012; 62: 142-147)
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Introduction
Pectus excavatum is a congenital deformity in which the 
sternum and the inferior costal cartilage area are depressed. 
This condition appears at birth and gradually progresses, 
developing to the menubrial area. The most severe depression 
occurs in the xiphoid process, and the incidence has been 
reported to be 0.01-0.1% [1]. In 1998, Nuss et al. [2] reported on 
a method that shows excellent esthetic results and improves the 
deterioration of lung function through the use of specially made 
metal rods fitted to the chest deformity of a patient. However, 
such surgical methods can induce severe postsurgical pain in 
pediatric patients due to expansion of the thorax. The pain can 
be controlled through the injection of narcotic analgesics or 
the injection of non-narcotic analgesics into the epidural space 
[3] or intramuscularly [4,5]. In children, injection through the 
epidural space is inappropriate, and major complications can 
occur [3,6]. Intravenous patient-controlled analgesia (IV-PCA) 
may be preferred by patients over intramuscular injection due 
to the lack of anxiety-induced pain with IV-PCA compared to 
that resulting from intramuscular injections [5].
Hydromorphone is a semi-synthetic opioid in which the 
hydroxyl group of morphine is substituted with oxygen and the 
double bond of 7-8 position is hydrogenated. Its lipid solubility 
is slightly higher than that of morphine, and the maintenance 
period is 3-5 hours, which is slightly shorter than that of 
morphine [7]. Hydromorphone has commonly been viewed as 
a second-line drug to morphine in the treatment of both acute 
and chronic pain [8].
Ketorolac is an effective drug with an analgesic potency 
com  parable to that of opioids. Its mechanism of action is the 
suppression of prostaglandin synthesis unrelated to opioid 
agents, and thus the use of ketorolac may facilitate return of 
gas  trointestinal function, reduce nausea, decrease respiratory 
depression, and improve patient satisfaction [9]. When ketorolac 
is used in combination with opioid agents, it exerts opioid-
sparing effects and improves analgesic action, and it is also used 
frequently in combination with opioid analgesics in IV-PCA [10-12]. 
Studies on the combined administration of hydromorphone 
and ketorolac have not previously been conducted. Therefore, 
in this study, by referring to the results of the supplemental 
admini  stration of ketorolac from several previous studies [9-12], 
hydromorphone and ketorolac were added to the basic IV-PCA.
It has been reported that the antagonist of the NMDA 
receptor, ketamine, reduces pain by suppressing the sensiti-
zation of the central nervous system and the development of 
opioid resistance [13,14]. Nesher et al. [15] and Kollender et 
al. [16] have reported that the additional injection of a small 
dose of ketamine resulted in a 50-60% reduction in the dose 
of morphine used in IV-PCA, and side effects such as nausea 
and vomiting were diminished. In addition, the need for 
supplemental analgesics was reduced. Studies on the effect of 
ketamine administered in combination with morphine have 
been reported; however, the effect of ketamine combined 
with hydromorphone and ketorolac on IV-PCA has not been 
examined. 
Therefore, the present study was undertaken to investgate 
the analgesic effect and side effects of co-administered small 
dose of ketamine on IV-PCA using hydromorphone and 
ketorolac for pain control after Nuss surgery. 
Materials and Methods
Among the 3-13-year-old pediatric patients scheduled for 
Nuss surgery at our institution, 44 patients (American Society 
of Anesthesiologists physical status I-II) were recruited for 
participation in this study. After obtaining approval from the 
hospital ethics committee, the subjects were divided randomly 
into two groups: the HO group was administered 3 μg/kg/hr 
hydromorphone, 0.05 mg/kg/hr ketorolac, and 0.1 mg/kg/day 
ondansetron, and the HK groups was additionally administered 
0.15 mg/kg/hr ketamine. The anesthesiologist providing 
anesthesia and observers participating in the pain and side 
effects assessments were unaware of the type of medication 
administered. All patients and parents were also blinded to 
their group assignment. There were 22 patients in each group, 
consent for pain control was obtained from parents, and the 
equipment and procedure were explained in detail. Patients 
with cardiac anomaly, Marfan syndrome, and other underlying 
cardiac diseases, patients with history of severe side effects 
after the use of opioid analgesics, patients with a history of 
psychiatric diseases, and cases of contraindication for the drugs 
used in our experiment were excluded. 
Atropine 0.01 mg/kg as premedication was injected intra-
muscularly 30 mins-1 hour before the induction of anesthesia. 
Blood pressure, pulse rate and peripheral oxygen saturation 
were measured prior to and during surgery. Thiopental sodium 
5 mg/kg, and rocuronium 0.6 mg/kg were administered 
intravenously and the endotracheal intubation was then 
performed. Anesthesia was maintained with oxygen 1 L/min, 
air 1.5 L/min and sevoflurane at 4-6 vol%, while controlled 
ventilation was performed to sustain end-tidal carbon dioxide 
(ETCO2) between 30 and 35 mmHg. Immediately prior to the 
incision of the skin, a bolus of 5 μg/kg hydromorphone and 0.1 
mg/kg ondansetron were injected for preemptive analgesic 
effect and for the prevention of movement and instability of 
vital signs due to severe pain. Hydromorphone 3 μg/kg/hr, 
ketorolac 0.05 mg/kg/hr and ondansetron 0.1 mg/kg/day in 
group HO and hydromorphone 3 μg/kg/hr, ketorolac 0.05 mg/
kg/hr, ondansetron 0.1 mg/kg/day and additional ketamine 144 www.ekja.org
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0.15 mg/kg/hr in group HK were started via an IV-PCA pump 
after a bolus injection of 5 μg/kg hydromorphone and 0.1 mg/
kg ondansetron. The total dose of drugs was determined to 
be 72 ml and the infusion rate, bolus dose and lock out time 
were set at 1 ml/hr, 0.5 ml, and 30 min respectively. The level of 
pain was measured at 1, 4, 8, 12, 24, and 48 hours after surgery 
according to the Modified CHEOPS [17] (Table 1) by a resident 
anesthesiologist. 
In addition, while assessing the level of pain, the satisfaction 
levels of patients were divided into four levels: very satisfied (4); 
generally satisfied (3); moderately satisfied (2); and unsatisfied 
(1). Satisfaction levels were recorded at 12, 24, and 48 hours 
after surgery based on verbal responses from the patients or 
parents. The delirium score and sedation scale after surgery 
were observed 1 hour after surgery. The delirium scores were 
divided into four levels: sleeping (1); awake but quiet (2); excited 
but able to be calmed (3); and very excited and thus difficult to 
calm (4). The sedation scale were classified as: alert condition 
(0); occasionally sleepy but able to answer questions (1); 
frequently sleepy but able to answer questions (2); responded 
to physical stimulation (3); and sleeping continuously without 
responding to physical stimulation (4). In addition, the nausea 
scale was recorded as none (1); dry heave (2); vomited once (3); 
and vomited several times (4). The side effects such as pruritus, 
hypoventilation, constipation, headache, dizziness, delirium, 
nightmare, and hallucination were assessed. For patients who 
presented with pain higher than a rating of 4 on the Modified 
CHEOPS, 0.5 mg/kg ketorolac was administered and recorded. 
For patients who vomited more than two times, 0.1 mg/kg 
ondansetron was administered and recorded. In addition, for 
observation of recovery of digestive system function, the time 
of the first gas release after surgery and the time of defecation 
were recorded.
Based on a previous studies [15,18,19], this study was powered 
to detect such a reduction with type 1 error of 0.05 (two tailed) 
and desired power of 0.8. Based on these assumptions, 20 
patients per group were required. We planned to enroll enough 
patients to obtain 22 patients per group. All measured values 
in this study are presented as a mean ± standard deviation and 
are described as the percentage of total patients. For statistical 
analysis, SPSS version 12.0 (SPSS Inc. Chicago, USA) was used. 
For the differences in age, height and weight between the 
groups, the Mann-Whitney test was applied. The differences 
in gender, side effects, and the additional administration of 
analgesics and antiemetics in the groups were analyzed using 
Fisher’s exact test. For comparison of the groups of the time 
points within a group, repeated measures of ANOVA were 
conducted, and followed by the post-hoc analysis method 
Bonferroni test. P values less than 0.05 were considered 
statistically significant.
Results
The ages, genders, weights and heights of the two groups 
did not show significant differences (Table 2). The Modified 
CHEOPS pain scores of the HO and HK groups after 1, 4, 8, 12, 
24, and 48 hours did not significantly differ (Fig. 1). The total 
administered volume via IV-PCA was significantly reduced in 
Table 1. Modified CHEOPS (Children's Hospital of Eastern Ontario 
Pain Scale)
Score 0 1 2
Cry
Facial
Verbal
Torso
Legs
Touch
No cry
Smiling
Positive
Neutral
Neutral
Not touching
Crying, moaning
Composed
None or other complaints
Shifting, tense, upright
Kicks, squirm, drawn up
Reach, touch, grab
Scream
Grimace
Pain complaint
Restrained
Restrained
Restrained
Table 2. Demographic Characteristics
Group HO 
(n = 22)
Group HK  
(n = 22)
Age (yr)
Weight (kg)
Height (cm)
Sex (M/F)
8.4 ± 6.6
25.8 ± 10.4
124.9 ± 22.3
14/8
7.3 ± 3.9
27.6 ± 14.0
124.7 ± 26.4
16/6
Values are expressed as mean ± SD or patient numbers. Group HO: 
hydromorphone 3 μg/kg/hr, ketorolac 0.05 mg/kg/hr, ondansetron 
0.1 mg/kg/day. Group HK: hydromorphone 3 μg/kg/hr, ketorolac 0.05 
mg/kg/hr, ondansetron 0.1 mg/kg/day and ketamine 0.15 mg/kg/hr.
Fig. 1. Changes of postoperative pain score using Children's Hospital 
of Eastern Ontario Pain Scale (CHEOPS) during 48 hr after emer-
gence in intravenous patient controlled analgesia (IV-PCA) groups. 
Data are represented as mean ± SD. There were no statistical 
differences between the groups with regards to the CHEOPS at 0.05 
levels. HO: hydromorphone + ketorolac group, HK: hydromorphone 
+ ketorolac + ketamine group.145 www.ekja.org
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the HK group compared to that in the HO group at 8, 24 and 48 
hours after the completion of surgery (Table 3). The satisfaction 
levels of patients or parents were not significantly different 
between the two groups (Fig. 2).
The delirium scores of the HO group and the HK group were 
1.3 ± 0.5 and 1.5 ± 0.6 and the sedation scores were 0.7 ± 1.0 and 
1.0 ± 1.1, respectively; no differences were detected between 
the two groups. Hypoventilation, dizziness, abdominal pain, the 
time of gas release, and defection time did not show differences 
between the groups. The score of nausea and vomiting and 
the number of antiemetic drug injections were also not 
different, nor was the additional administration of analgesics. 
Nevertheless, pruritus was observed more frequently in the HO 
group than in the HK group (Table 4). 
Discussion
Nuss surgery is a minimally invasive procedure; however, 
postsurgical pain is a major problem associated with this 
technique [2]. To prevent postsurgical lung complications or the 
displacement of the metal rod, bed rest after pectus excavatum 
surgery is crucial [6]. In addition, the forceful movement of the 
sternum causes substantial pain in the chest and back of the 
patient. Since the chest and back correspond to the dermatomes 
in a wide area from the 1-10 thoracic vertebrae, pain is difficult 
to control [20]. Thoracic epidural block is an effective method 
for pain control; however, because surgery subjects are often 
children, the technique is difficult. It is also complicated to 
maintain catheters, and hypotension may develop after the 
procedure [20]. Therefore, IV-PCA is considered to be the most 
effective pain control method after Nuss surgery.
Major drugs used for IV-PCA are morphine, hydromorphone, 
meperidine, fentanyl and other opioid analgesics, often used 
in combination with a non-steroid anti-inflammatory drug 
(NSAID) [9]. In performing PCA, the side effects of opioid anal-
gesics such as hypoventilation, drowsiness, nausea, vomiting, 
and pruritus act as limiting factors. Numerous studies have 
been conducted to obtain effective analgesic effects while 
reducing such side effects [8-10,12,21]. 
Even though hydromorphone is a potent analgesic for the 
management of acute and chronic pain, it is the second drug 
of choice after morphine. The onset time of hydromorphone is 
within 5 minutes, which is slightly faster than that of morphine 
and the maximum effect is between 10 and 20 minutes [7]. The 
maintenance period is 3-5 hours, which is slightly shorter than 
Table 3. Change of Total Infused IV-PCA Volume (ml) 
Time (h) 1 4 8 12 24 48
IV-PCA volume (ml)
    HO
    HK
3.3 ± 0.3
3.2 ± 0.2
7.7 ± 0.4
7.4 ± 0.3
13.0 ± 0.6
10.8 ± 0.4*
16.9 ± 0.7
15.3 ± 0.5
30.8 ± 0.8
27.7 ± 0.6*
57.8 ± 2.5
50.8 ± 1.9*
Values are expressed as mean ± SD. Group HO: hydromorphone 3 μg/kg/hr, ketorolac 0.05 mg/kg/hr, ondansetron 0.1 mg/kg/day. Group HK: 
hydromorphone 3 μg/kg/hr, ketorolac 0.05 mg/kg/hr, ondansetron 0.1 mg/kg/day and ketamine 0.15 mg/kg/hr. *P < 0.05 compared with group HO.
Fig. 2. Satisfaction of pain control was assessed by parents at post-
operative 12, 24 and 48 hrs and expressed as excellent, good, fair and 
poor. There were no statistical differences between the groups with 
regards to satisfaction at 0.05 levels. But the parents of both groups 
were generally satisfied with pain control. HO: hydromorphone + 
ketorolac group, HK: hydromorphone + ketorolac + ketamine group.
Table 4. Postoperative Effects of Test Drug Treatments
Group HO
(n = 22)
Group HK
(n = 22)
Delirium scale
Sedation scale
Nausea scale
Anti-emetics
Abdominal pain
Gas-out time (hr)
Defecation time (hr)
Pruritus
Dizziness
Dyspnea
Painkiller injection
1.3 ± 0.5
0.7 ± 1.0
2.1 ± 0.8
7/22 (32%)
6/22 (27%)
26.5 ± 12.2
75.2 ± 23.3
7/22 (32%)
1/22 (5%)
0/22 (0%)
12/22 (55%)
1.5 ± 0.6
1.0 ± 1.1
2.4 ± 1.2
9/22 (41%)
5/22 (23%)
32.2 ± 16.1
69.2 ± 25.9
1/22 (5%)*
2/22 (9%)
1/22 (5%)
13/22 (59%)
Values are expressed as mean ± SD or absolute numbers of the group 
numbers and as a percentage. Group HO: hydromorphone 3 μg/kg/
hr, ketorolac 0.05 mg/kg/hr, ondansetron 0.1 mg/kg/day. Group HK: 
hydromorphone 3 μg/kg/hr, ketorolac 0.05 mg/kg/hr, ondansetron 
0.1 mg/kg/day and ketamine 0.15 mg/kg/hr. *P < 0.05 compared 
with group HO.146 www.ekja.org
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that of morphine [7]. The equianalgesic ratio for parenteral 
morphine to parenteral hydromorphone is 5 : 1-7 : 1 [8]. 
Chang et al. [22] reported that there is little difference between 
morphine and hydromorphone in terms of analgesic efficacy 
and similar side effects except pruritus. Rapp et al. [21] reported 
that the levels of pain control were achieved by these two 
drugs and side effects were similar between two drugs, while 
hydromorphone improves the moods of patients and morphine 
caused less cognitive impairment. Therefore, hydromporphone 
is a suitable alternative to morphine.
Ketorolac administered in our study is a powerful drug with 
an analgesic potency similar to those of opioid drugs, and it is 
frequently administered in combination with opioid analgesics 
[9]. Picard et al. [11] have reported that the co-administration 
of morphine and ketorolac results in superior analgesic effects 
by up to to 2.6 times compared with those of the drugs admini-
stered alone. In addition, Kim et al. [12] reported that the 
addition of ketorolac to fentanyl resulted in the same analgesic 
efficacy but less nausea, vomiting and drowsiness. Studies on 
the combined administration of hydromorphone and ketorolac 
have not previously been conducted. In this study, by referring 
to the results of the supplemental administration of ketorolac 
from several previous studies [9-12], hydromorphone and 
ketorolac were added to the basic IV-PCA.
The administration of a small dose of ketamine is defined as 
a single injection of less than 1 mg/kg or continuous injection 
of less than 0.1-0.2 mg/kg/hr for pain management [23]. It is 
controversial whether the simultaneous injection of a small 
amount of ketamine and opioid analgesics reduces the dose 
of opioid analgesics needed immediately after surgery and 
afterward [14-16,24]. Nesher et al. [15] have reported that 
in patients who underwent open chest surgery, in contrast 
to those given only morphine, the dose of morphine was 
reduced by approximately 50% in the group injected with 
simultaneous ketamine and morphine. In addition, the pain 
score and postsurgical nausea and vomiting were reduced, and 
the frequency of additional analgesics was reduced by half. 
Kollender et al. [16] have reported that the addition of ketamine 
to morphine allowed the dose of morphine to be reduced by 
60%, and lower and more stable pain scores and a shorter 
time of IV-PCA application were observed. In our study, the 
total dose of hydromorphone and ketorolac was reduced by 
approximately 13%. Although this reduction level was different, 
the results appear to be in agreement with previous other 
studies. It is thought that the discrepancy in results was due to 
the additional injection of ketorolac and the onset time of the 
effect of hydromorphone was shorter compared with morphine, 
thus the necessity of additional administration of analgesics to 
reach the required effective dose was decreased. Urban et al. [18] 
have reported that postsurgical pain scores were reduced when 
ketamine was co-injected with hydromorphone in continuous 
IV-PCA. Total amount of hydromorphone used during post-
operative 48 hours was reduced by 25%. However, this was not 
significant because of the large standard deviation. 
In our study, the incidences of side effects did not show 
differences in the two groups except for pruritus. Additionally, 
the unpleasant feelings or confusion that may be induced by 
ketamine were not observed, and hypoventilation did not 
develop. The nausea and vomiting scores of the two groups 
were not different, which contradicts the results of previous 
studies that found the combined administration of morphine 
and ketamine resulted in a reduced incidence of nausea [16,25]. 
This discrepancy is thought to be due to other factors such as 
relatively fewer side effects of hydromorphone in comparison 
with those of morphine, the combined administration with 
ketorolac, the anesthetic method, and the surgical method 
(Nuss procedure). In regard to pruritus, the incidences in the 
HO group and the HK group were 7/22 (32%) and 1/22 (5%), 
respectively, and it was approximately seven times more 
prevalent in the HO group. Javery et al. [25] and Murdoch 
et al. [26] have also reported the reduction of pruritus in the 
group receiving additional ketamine. Such effects of ketamine 
have been reported to be due to the suppression of the central 
sensitization and reduced tolerance to opioid analgesics. 
To conduct studies on the addition of a small dose of keta-
mine as a continuum of the prior studies is thought to be a 
superior investigation method. Therefore, we believe that the 
study on the effect of additional ketorolac on hydromorphone 
in IV-PCA after Nuss surgery must preced before this study 
and this is the limitation of this study. Nevertheless, previous 
studies have shown that combination treatment with ketorolac 
improved the analgesic effects of opioid analgesics and reduced 
the total dose in comparison with those of the treatment with 
opioid analgesics alone [10,11]. In consideration of the ethical 
issues of the dose of opioid analgesics administered to the 
control group patients as well as in consideration of the clinical 
effects on pain control after the combination administration of 
hydromorphone with ketorolac, the effect of a small amount of 
ketamine on pain was examined. For the control of acute pain 
in patients, the administration of additional drugs in multistep 
methods may be ineffective for pain control. If pain is not 
treated at the appropriate times, injury to nociceptive nerves 
and central sensitization may be induced, leading to allodynia 
and hyperpathia. Hence, Good et al. [27] suggested triple-agent 
therapy involving the co-injection of opioid analgesics, NSAIDs, 
and ketamine in the early period. This is similar to our method 
for patients undergoing Nuss surgery, a procedure which induces 
severe post-operative pain. 
In conclusion, the administration of IV-PCA with hydro-
morphone, ketorolac, and a small dose of ketamine resulted in 147 www.ekja.org
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a reduction of the total administered dose of hydromorphone 
and ketorolacand the incidence of pruritus was significantly 
reduced without increasing other side effects. Therefore, if IV-
PCA is used for effective pain control after Nuss surgery for the 
correction of pectus excavatum in children, the combination 
of a small amount of ketamine with hydromorphone and keto-
rolac is recommended.
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